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Abstract 
The parasite Toxoplasma gondii is thought to be prevalent in humans, although the infection is 
typically latent. Cats are the definitive hosts of the parasite and it is believed the parasite is 
transmitted to humans through contact with cat feces. T. gondii is of particular interest to 
researchers because of its proposed effects on the central nervous system in humans. The 
parasite is able to enter the central nervous system and affect dopamine metabolism. Increased 
dopamine levels in infected cells primarily cause changes in the components of the limbic 
system. This has led to the proposed effects of increased impulsivity and aggression in people 
with active T. gondii infections. One of the most interesting effects of T. gondii in humans is its 
proposed contribution to schizophrenia. Schizophrenia alone is not well understood as to what 
causes the illness. There are studies that have hypothesized an increased level of T. gondii 
antibodies is correlated with increased risk for development of schizophrenia. This hypothesis is 
intriguing and requires further investigation. 
 
 
 
 
 
 
 
 
 
TOXOPLASMA GONDII  4 
Introduction 
 Toxoplasma gondii is a fairly common parasite in the United States, possibly infecting 
about forty million Americans, although most of the infections remain latent and never cause 
any problems (Centers for Disease Control and Prevention (CDC), 2018). However, an active T. 
gondii infection is dangerous especially for pregnant women and immunocompromised 
individuals because these populations are at risk for reactivation of the T. gondii infection and 
development of life-threatening toxoplasmic encephalitis (Carruthers and Suzuki, 2007). Many 
of the symptoms are typical flu-like symptoms such as fever and muscle aches and pains, but in 
more serious infections, T. gondii can infect neurons, and this could interfere with dopamine- 
and glutamate-mediated neurotransmission. The consequences of these changes in humans 
can be extreme. In congenital infections of T. gondii for example, the parasitic infection can 
cause severe neurological and ophthalmologic disease (Carruthers and Suzuki, 2007). 
Physiological changes are only part of the danger of T. gondii infection. Perhaps the most 
intriguing aspect of T. gondii is its ability to alter behavior in rats and also in humans. It has 
been suggested that this protozoan parasite could be a contributing factor to altering human 
behaviors such as increasing aggressiveness and impulsivity. T. gondii may also have a role in 
depression, anxiety, and most interestingly schizophrenia. Since the 1950s, research on T. 
gondii infection as a contributing causal factor to schizophrenia has increased. Presented here 
are studies examining physiological and behavioral effects of T. gondii infection in rats and 
exploring if similar effects can be found in humans. Also presented here is an assessment of a 
possible cause and effect relationship between T. gondii and schizophrenia. In order to 
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understand this parasite and its effects, we will first present the basic biology of the T. gondii 
parasite, including its life cycle, hosts, reproduction, and mechanisms of infection. 
Life Cycle and Reproduction of Toxoplasma gondii 
Hosts and Primary Forms 
 Toxoplasmosis is an infection caused by a single-celled, intracellular protozoan parasite 
Toxoplasma gondii. The definitive hosts of the parasite are members of the family Felidae 
which consists of domestic cats and their relatives and these hosts can infect most warm-
blooded species of animals. The primary forms of T. gondii are oocysts, tachyzoites, and 
bradyzoites. Oocysts are only produced in cats, which are the definitive hosts, and then passed 
in the feces and ingested by other animals to cause infection. The tachyzoites are the rapidly 
multiplying form of T. gondii which localize to muscle tissues and the central nervous system 
where they change into tissue cyst bradyzoites. The bradyzoites are the slowly multiplying, 
encysted form of the parasite and cause the host immune response to occur. The bradyzoites 
will transform back into tachyzoites when entering a new host (Nguyen, 2006). The tachyzoite is 
the life stage of the parasite which causes physiological and behavioral changes in the host 
during an active infection. 
Life Cycle and Reproduction 
The life cycle of T. gondii begins with unsporulated oocysts being shed in the feces from 
an infected cat. Intermediate hosts are then infected after ingestion of soil, water, or plant 
material contaminated with oocysts. The oocysts become tachyzoites shortly after ingestion by 
the intermediate hosts and localize in the neural and muscle tissues before developing into 
tissue cyst bradyzoites. More cats can become infected by consuming intermediate hosts, such 
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as birds, that have tissue cyst bradyzoites. Other animals for human consumption such as pigs, 
sheep, and certain birds can be infected with tissue cysts after ingestion of sporulated oocysts 
in the environment. This results in infection of the human after ingestion of contaminated 
meat. Once in the human, T. gondii forms tissue cysts which persist throughout the host’s 
lifetime (CDC, 2018). Reproduction of the parasite only occurs sexually in cats, while asexual 
reproduction occurs in intermediate hosts (Luna, 2016). Figure 1 is a depiction of the life cycle 
of T. gondii beginning with fecal oocysts from cats and ending in tissue cysts in humans. 
 
Figure 1. Life Cycle. From “Toxoplasmosis,” by Centers for Disease Control and Prevention 
Division of Parasitic Diseases and Malaria, 2017, 
https://www.cdc.gov/parasites/toxoplasmosis/biology.html. In the public domain. 
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Mechanisms for Human Infection 
 T. gondii infects about forty million people in the United States, but very few people 
have symptoms because a healthy person’s immune system normally is able to prevent the 
parasite from becoming active and causing illness. Infection occurs in humans through eating 
undercooked, contaminated meat such as pork, lamb, or venison, not washing hands 
thoroughly after handling contaminated meat, using contaminated utensils to prepare other 
food, drinking contaminated water, swallowing the parasite through contact with cat feces 
containing T. gondii through cleaning a litterbox, touching or ingesting anything that has come 
into contact with cat feces, or ingesting contaminated soil. Vertical transmission occurs through 
congenital transmission from mother to child during pregnancy. Horizontal transmission occurs 
through infected organ transplants or blood transfusions. Cultural habits also play a role in 
infection because of the food choices made by some cultures to ingest animals that are more 
likely to be infected. There are also geographical areas where the environment is more likely to 
have contaminated material (CDC, 2018).  
Symptoms and Treatment 
 There are three strains of T. gondii, type I being the most aggressively growing strain 
and types II and III the less aggressive, but still disease-causing strains (Carruthers and Suzuki, 
2007). Although most infections are latent and have no symptoms, those infections that do 
produce symptoms result in flu-like symptoms with swollen lymph glands and muscle aches and 
pains that last for one month or more. Ocular symptoms include reduced or blurred vision, pain 
with bright light, redness of the eyes, and tearing (CDC, 2018). Other general symptoms of an 
infection can occur such as cervical lymphadenopathy, fever, malaise, night sweats, myalgia, 
TOXOPLASMA GONDII  8 
sore throat, and rash (Nguyen, 2006). The biggest danger is for pregnant women and immune 
compromised patients because their risk of infection and developing symptoms is greater due 
to decreased immunity. The part of the body that is most affected in humans is the brain 
(Mendez, 2017).  
Treatment for those who are infected and showing symptoms is not necessary, but 
there are medications available for treatment such as sulphadiazine and pyrimethamine. 
Sulphadiazine and pyrimethamine are frequently used in combination for treatment of T. gondii 
infections because these drugs have synergistic activity against the replicating form of T. gondii, 
the tachyzoites. Sulphadiazine and pyrimethamine inhibit the parasite enzymes 
dihydropteroate synthase (DHPS) and dihydrofolate reductase (DHFR) (Bilgin et al., 2013). DHPS 
is an enzyme involved in the folate synthesis pathway which is essential for synthesizing amino 
acids required for function and growth of bacteria and parasites (Hall and Petek, 2012). DHFR is 
an enzyme involved in the reduction of dihydrofolate to tetrahydrofolate. Tetrahydrofolate is a 
precursor for purine synthesis, and purines are necessary in DNA synthesis and replication 
(Gagné, 2014). Inhibition of DHPS and DHFR by sulphadiazine and pyrimethamine therefore 
inhibits the growth and replication of the tachyzoite form of the T. gondii parasite. 
Effects of T. gondii on Rats 
The T. gondii parasite sparks interest among researchers because of its proposed 
unusual ability to alter not only the behavior of rats, but possibly that of humans as well. Rats 
are more ideal for use in studies on T. gondii instead of mice because T. gondii infection is very 
virulent in mice, whereas infection in rats in a more accurate representation of the clinical 
condition in humans (Bay-Richter et al., 2019). It has been proposed that rats infected with the 
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parasite lose fear of cats because they lose fear of the smell of cat urine, which normally serves 
as a danger signal for rats. Instead, the rats feel a sort of sexual attraction to the smell of the 
cat urine because T. gondii can cause changes in neural activity in certain areas of the brain 
which control fear (Bucklin, 2016). One study demonstrates that T. gondii infected rats display 
an attraction specifically for feline urine while maintaining their aversion to urine of other 
predators (Bay-Richter et al., 2019). Another study performed in 2000 by Berdoy et al. used test 
pens with four different scents in each corner, rat urine, water, rabbit urine, and cat urine, to 
test how T. gondii infection affected the amount of times the infected rats visited each of the 
four sites. As can be seen in Figure 2, infected rats visited the sites with water, rat urine, or 
rabbit urine about the same amount as the uninfected control rats. The figure also shows that 
infected rats visited the corner of the pen with cat urine significantly more than the uninfected 
rats, enforcing the hypothesis that T. gondii alters the behavioral response of rats to cat urine 
(Berdoy et al., 2000). 
 
 
 
 
 
 
Figure 2. Mean numbers of visits to the four scented areas in the outdoor pens over one night. 
From “Fatal attraction in rats infected with Toxoplasma gondii,” by M. Berdoy et al., 2000, The 
Royal Society, 267, 1591. 
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It has been speculated that the ability of T. gondii to modify the behavior of its 
intermediate host has evolved because this increases its chances of entering a cat, the 
definitive host (Yong, 2008). This is known by some as the manipulation hypothesis where a 
parasite manipulates the behavior of its intermediate host to enhance its transmission into the 
definitive host (Webster, 2007). Sexual reproduction of T. gondii can only occur in feline hosts, 
so there are strong selective pressures on the parasite to evolve mechanisms to enhance its 
transmission into the definitive feline hosts from the intermediate hosts to complete its life 
cycle (Webster, 2007). In a study by Bay-Richter et al. (2019), T. gondii infected rats displayed 
increased levels of the cytokines IL-4, IL-6, IL12-p70, GLP-1, IL-1α, and CM-CSF, cytokines known 
to be associated with anxiety-like behaviors, which the researchers suggest is one of the 
probable causes of alteration of rat behavior.  
The results of the study by Bay-Richter et al. (2019) show that elevation of the 
mentioned cytokines may be directly related to anxiety-like behavior through the use of various 
behavioral tests such as the light-dark box test. In this test, the rat is placed in a box where one 
half of the box is dark and has a lid while the other half is white, open, and brightly illuminated. 
The rat is able to move freely between the compartments because of the presence of an open 
door. As Figure 3 shows, both the healthy control rats (FRL) and genetically vulnerable rats (FSL) 
spent less time in the white compartment of the box if they were infected with T. gondii. The 
Flinders sensitive line (FSL) rats are rats which have been shown to display symptoms of 
depression and anxiety due to a genetic predisposition (Bay-Richter et al., 2019). T. gondii 
causes anxiety-like behaviors to increase, and in this test, an anxious rat prefers to be in the 
safety of the dark, enclosed half of the box. This may seem contradictory to the effect of T. 
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gondii increasing rat preference for cat urine, but it is likely that these are two different, 
unrelated effects. The increased preference for cat urine is an evolutionary advantage for the 
parasite, but the increased anxiety in T. gondii infected rats could be a side effect caused by the 
host responding to the parasite. This increased anxiety was also associated with increased 
levels of cytokines known to be involved in anxiety-like behaviors. 
 
 
 
 
 
 
 
Figure 3. Time spent in white compartment of the light-dark box. From “Latent toxoplasmosis 
aggravates anxiety- and depressive-like behaviour and suggests a role of gene-environment 
interactions in the behavioural response to the parasite,” by C. Bay-Richter, 2019, Behavioural 
Brain Research, 364, 136.  
 
Webster (2007) presented additional plausible hypotheses for the alterations in the 
behavior of rats infected with T. gondii, such as histopathological, immunological, and 
neuromodulatory changes. In infected rats, multi-focal lesions and histopathological changes in 
the cyst-containing regions of the brain have been observed. Some of these histopathological 
changes include inflammatory granulomatous changes of perivascular areas of the brain, 
TOXOPLASMA GONDII  12 
progressive deposition of necrotic material, and vesicular occlusion and sclerosis (Webster, 
2007). Supplementing the hypothesis of increased levels of cytokines in infected rats causing 
behavioral changes, Webster (2007) proposed that latent toxoplasmosis can cause permanently 
increased levels of mRNA of the cytokines TNFα and IL-10. It is probable that the local immune 
response in the brain required to keep T. gondii dormant, may alter the levels of these 
cytokines and those listed by Bay-Richter et al. (2019) resulting in changes in neuromodulator 
levels (Webster, 2007). In turn, neuromodulation could be the main mechanism of changing the 
expression of host behavior. Blocking the N-methyl-D-aspartic acid receptors in the amygdala, 
which are normally anxiogenic, and use of serotonin antagonists causes rats to become fearless 
to cat urine, in a similar manner to T. gondii infected rats (Webster, 2007). Some of the main 
neurotransmitters proposed by Webster (2007) to cause these types of behavioral changes in 
infected rats are homovanillic acid, norepinephrine, and dopamine. These hypotheses of how T. 
gondii modifies behavior in rats has led researchers to study the effects of T. gondii on human 
behavior with these hypotheses as starting points. 
Proposed Effects of T. gondii in Humans 
Potential Link to Schizophrenia 
 Schizophrenia is a complicated disease for which the cause is not specifically known. 
Schizophrenia is not caused by just one main, environmental, or genetic factor, but it is a 
disease caused by multiple factors which are additive in their effects. Since the 1950s, it has 
been proposed that toxoplasmosis, the disease manifestation of T. gondii infection, may be a 
contributing cause of schizophrenia because sometimes the transient symptoms of 
toxoplasmosis resemble the clinical signs of paranoid schizophrenia. (Flegr, 2015). As previously 
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stated, cats are the definitive hosts of the T. gondii parasite, and a study by Torrey and Yolken 
(1995) pointed out that the risk factor common to both schizophrenia and toxoplasmosis is 
contact with cats. The questions being addressed in human studies are, once infected with T. 
gondii, which parts of the human body are most affected, and what changes does the parasite 
cause that can lead to schizophrenia? 
Entering and Infecting the Central Nervous System 
Some of the main influences of T. gondii on human behavior include pseudo-kinase 
proteins involved in the virulence of the parasite, changes in dopamine metabolism, changes in 
trait aggression and impulsivity, and the possible contribution to schizophrenia and other 
mental disorders (Cook et al., 2015). T. gondii, like other brain invading parasites, must cross 
the blood brain barrier to be able to affect cells within brain tissues. T. gondii has three 
methods for crossing the blood brain barrier: paracellular crossing, transcellular crossing, and 
by an infected immune cell crossing the blood brain barrier and bringing the parasite with it. 
Paracellular entry occurs when T. gondii crosses through the tight junctions of endothelial cells 
(Mendez, 2017). The parasite traverses the intestinal or placental epithelium as a free parasite 
by paracellular migration and enters circulating cells such as macrophages or dendritic cells 
(Carruthers and Suzuki, 2007). Transcellular migration occurs when a cell becomes infected, 
replicates, and lyses or egresses from the basolateral side. Tachyzoites are the form of the 
parasite which cross the blood brain barrier (Mendez, 2017). Once T. gondii tachyzoites have 
crossed the blood brain barrier and entered the central nervous system, the parasite persists as 
cysts mostly in neurons and astrocytes. The major difference between infection of these two 
cell types is that astrocytes are typically able to clear infections caused by intracellular parasites 
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such as T. gondii, but neurons are unable to clear T. gondii infections on their own. Therefore, 
T. gondii infection may initially be present in astrocytes and neurons, but persistent infection 
occurs in neurons where the majority of cysts are (Mendez, 2017). 
Contribution of Pseudo-Kinases to Virulence 
 One of the characteristics of T. gondii that is perhaps the most striking is its ability to 
infect almost any type of warm-blooded animal. Reese et al. (2011) raised the question of how 
T. gondii is able to infect various types of cells in a host of warm-blooded animals. Toxoplasma 
gondii secretes many different proteins into host cells from organelles the parasite has called 
rhoptries and dense organelles. One of these proteins is ROP18 which is a catalytically active 
kinase that phosphorylates and inactivates host GTPases involved in the immune system. 
ROP16 is another protein which is a tyrosine kinase that phosphorylates the STAT proteins in 
the host (Reese et al., 2011). STAT proteins are intracellular transcription factors which are 
involved in cell immunity, proliferation, apoptosis, and differentiation. ROP5 is another protein 
which acts as a catalytically inactive pseudo-kinase and was found to act independently of 
ROP16 and ROP18. Although all three proteins are involved in the virulence of the T. gondii 
parasite, ROP5 appears to play a larger role than ROP 18 in in vivo infection. It is proposed that 
ROP5, as a catalytically inactive pseudo-kinase, may function in a similar manner to other 
known pseudo-kinases as a molecular scaffold which can coordinate signal transduction. Reese 
et al. (2011) suggested that differences in the virulence of different strains of T. gondii are 
caused by how ROP5 interacts inside the host cells, and how it can interact with other parasite 
proteins to affect host signaling. There are different copy numbers and different alleles of the 
ROP5 protein in the different strains of the T. gondii parasite, and this diversity of ROP5 as well 
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as other parasitic proteins is what allows T. gondii to infect a multitude of warm-blooded 
animals (Reese et al., 2011). 
Dopamine Metabolism 
 Parasite proteins such as the ROP proteins can affect signaling in the host cells. One 
important signaling molecule affected by the T. gondii parasite is the neurotransmitter 
dopamine. The amygdala and hippocampal areas of the brain are part of the limbic system and 
dopaminergic neurons in other portions of the brain receive information from these areas 
(Haber and Fudge, 1997). These other portions of the brain with dopaminergic neurons are the 
nucleus accumbens and ventral tegmental area (Haber and Fudge, 1997). In a study by 
Prandovsky et al., it was found that the levels of dopamine in the brains of mice chronically 
infected with T. gondii were elevated by fourteen percent, while the levels of other 
neurotransmitters remained the same (2011). Dopamine staining revealed that the 
neurotransmitter localized primarily in the T. gondii tissue cysts. To exclude the possibility that 
a neurotransmitter other than dopamine was causing these results, exogenous serotonin was 
added, and this did not affect the dopamine staining, confirming dopamine, or possibly the 
precursor to dopamine, L-DOPA, was causing the staining. Not only were dopamine levels 
increased in infected cells, but dopamine release levels were also elevated in infected cells. 
Tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis, was found to be 
localized in the tissue cysts of the brains of mice chronically infected with T. gondii (Prandovsky 
et al., 2011).  
 Gaskell et al. (2009) identified two genes for tyrosine hydroxylases in the genome of T. 
gondii. These genes are likely responsible for the increased production of dopamine in T. gondii 
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tissue cysts (Flegr, 2015). The increased dopamine synthesis could be a biological adaptation of 
T. gondii to manipulate the behavior of intermediate hosts to enhance transmission. Dopamine 
has been known to play a role in schizophrenia. The increased levels of dopamine caused by T. 
gondii infection in specific areas of the brain may be responsible for some of the positive 
symptoms of schizophrenia such as delusions and hallucinations (Flegr, 2015). 
 Why is alteration of dopamine metabolism an important feature of the T. gondii 
parasite? Dopamine metabolism mediates host behavior based on levels of dopamine and its 
release. Increases in dopamine synthesis may also be a contributing factor to schizophrenia. 
Areas of the brain that are particularly susceptible to changes in dopamine levels are the 
nucleus accumbens and ventral tegmental area which receive information from parts of the 
limbic system (Haber and Fudge, 1997). These areas play roles in movement in the basal 
ganglia, reward to stimuli, pleasure, and dependency in the nucleus accumbens and 
hippocampus, motivation and cognition, and species and stimuli specific fears in the amygdala. 
Therefore, changes in dopamine metabolism in the amygdala help to explain how T. gondii, 
through altering dopamine levels and release, can cause rats to lose their fear of cat urine.  
Trait Aggression and Impulsivity 
 In addition to its effects on rats, dopamine changes caused by T. gondii may be 
responsible for aggression and impulsivity changes in normally healthy adult humans. Cook et 
al. studied how T. gondii infection may cause or worsen trait aggression or impulsivity directly, 
or through host immune activation (2015). In rats, elevated dopamine release in the nucleus 
accumbens was correlated with increased firing of ventral tegmental neurons, and this was 
observed during aggressive encounters. Blocking the dopamine receptors of rats in these brain 
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areas caused anti-aggressive effects. This conclusion reached by others contradicts the results 
from Cook’s study. Cook suggests lower dopamine production and storage capacity may be 
associated with increased aggression (Cook et al, 2015). Another explanation is that pro-
inflammatory cytokines and anti-inflammatory signals may both be responsible for these 
behavioral effects. Pro-inflammatory cytokines induce increased breakdown of tryptophan. 
Tryptophan is necessary for T. gondii replication, and pro-inflammatory cytokines serve as a 
major line of defense against the T. gondii parasite because they break down tryptophan. A 
consequence of breaking down tryptophan is decreased serotonin synthesis because serotonin 
is synthesized from tryptophan. Cook hypothesizes that this immune reaction to T. gondii 
infection, breakdown of tryptophan, leads to impulsivity and aggression via decreased 
serotonin synthesis (2015). Anti-inflammatory signals are released from the parasite to 
decrease the host immune response, resulting in a temporary reactivation of the T. gondii 
infection because tryptophan levels would increase, allowing the parasite to replicate again. It 
is therefore not the parasite directly causing increased aggression and impulsivity, but rather 
the host’s immune response to the parasite. 
Proposed Link to Schizophrenia 
 Overview of schizophrenia. Perhaps one of the most debatable and controversial 
effects of T. gondii infection in humans is the possible link between T. gondii and increased risk 
of schizophrenia. Schizophrenia is a mental disorder in which the person interprets reality 
abnormally and it may result in hallucinations, disordered thinking, delusions, and behavior that 
impairs their ability to function from day to day (Mayo Clinic, 2018). Although there is not a 
definite cause of schizophrenia, issues with normal brain neurotransmitters such as dopamine 
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and glutamate may contribute to the disorder. The Mayo Clinic lists increased immune system 
activation from inflammation or autoimmune diseases, and pregnancy complications such as 
exposure to toxins or viruses that can affect brain development of the fetus as other potential 
risk factors for schizophrenia. There are increasing studies producing results which indicate T. 
gondii plays a role in schizophrenia along with other environmental and genetic factors. 
 Prevalence of schizophrenia and T. gondii. Schizophrenia affects about one percent of 
the population of the United States, while T. gondii, normally in a latent form, affects about 
eight percent of the population, although the numbers of those infected with latent T. gondii 
vary because of lack of testing for the parasite for normally healthy adults. The prevalence of T. 
gondii varies between countries with some studies stating it is 10 to 30% in North America, 
Southeast Asia, and Northern Europe, 30 to 50% in Central and Southern Europe and Northern 
Africa, and the highest prevalence of the parasite is found in areas where the climate is more 
tropical including South America and tropical African countries (Esshili et al, 2016). One could 
argue that it is mere coincidence that there is an association between T. gondii and 
schizophrenia because of the prevalence percentage of the parasite, but there are multiple 
studies that support an association between schizophrenia and T. gondii as a sort of cause and 
effect relationship. Some hypotheses for how T. gondii contributes to schizophrenia include 
increased dopamine synthesis and changes in tryptophan synthesis. 
 Tryptophan changes in T. gondii infection. It has already been stated that T. gondii 
requires tryptophan in order to replicate. What is so significant about tryptophan that the 
parasite cannot replicate without it? The immunological reaction to T. gondii may disrupt 
tryptophan metabolism by the infected cells secreting large amounts of kynurenic acid (KYNA) 
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through the indoleamine-2,3-dioxygenase (IDO)-mediated tryptophan degradation pathway 
(Burgdorf et al., 2019). Latent T. gondii causes production of the enzyme IDO and another 
enzyme, tryptophan dioxygenase (TDO), in astrocytes. These enzymes are responsible for 
breaking down tryptophan which prevents the parasite from replicating and keeps it in the 
latent form. Degradation of tryptophan by IDO produces kynurenine. Kynurenine is either 
metabolized to KYNA which is an antagonist of the glutamate N-methyl-D-aspartate (NMDA) 
receptor and nicotinic receptors or hydroxylated to quinolinate which is a potent NMDA 
neurotoxic agent (Burgdorf et al., 2019). The NMDA receptors are glutamatergic receptors, 
which are excitatory, so antagonizing or inhibiting the NMDA receptors results in decreased 
excitability meaning the T. gondii infection will remain latent. High levels of KYNA have been 
found in the cerebrospinal fluid of schizophrenic individuals, indicating these same individuals 
may have a latent T. gondii infection. This study by Burgdorf et al. (2019) thus shows that in 
addition to dopaminergic neurotransmission, glutamatergic neurotransmission is also affected 
by T. gondii.  
Relationship between IgG antibodies against T. gondii and schizophrenia. One study 
used neonatal blood samples that had been stored on filter papers and compared them to 
current blood samples from the same subjects if they were still living (Mortensen et al., 2007). 
The researchers compared levels of IgG antibodies for T. gondii in the samples from the adult 
subjects from whom the neonatal samples were taken at an earlier time and compared them to 
the levels of IgG antibodies for T. gondii in control subjects without the parasite. It was found 
that subjects who later developed schizophrenia had significantly elevated levels of IgG 
antibodies against T. gondii compared to the control subjects, suggesting there is an association 
TOXOPLASMA GONDII  20 
between the parasite and the disorder. This finding was also apparent in a similar study by 
Esshili et al. where IgG antibody to T. gondii was 74.8% in schizophrenic patients compared to 
53.8% in the control subjects (Esshili et al., 2016). Subjects who later developed bipolar 
affective disorder or other affective disorders did not have elevated IgG antibodies against T. 
gondii. The main conclusion reached from Mortensen’s study is that there is a significant 
correlation between elevated levels of IgG antibodies against T. gondii and the diagnosis of 
schizophrenia in the same subjects before the age of eighteen (2007). 
Interpretation of Mortensen et al. (2007) and Esshili et al. (2016) study results. 
Perinatal infection by other viruses or parasites such as rubella or cytomegalovirus were ruled 
out as the cause of increased antibody levels in these two studies because the levels of IgM 
antibodies, which are the first antibodies to respond to a new infection, were low in those 
subjects later diagnosed with schizophrenia. This is not to say that perinatal T. gondii infection 
causes schizophrenia to develop later, but rather that the conclusions of the study are one way 
to interpret the results. There are many possibilities for elevated antibodies at this stage and 
the cause of schizophrenia is not known. Instead, the elevated levels of IgG antibodies against 
the parasite are likely to indicate cat ownership since cats are the only definitive hosts of T. 
gondii. A further interpretation given by Mortensen (2007) is that exposure to a cat during early 
childhood is associated with increased risk of schizophrenia developing later in the child’s life. 
Although these are interpretations of the results, T. gondii is a plausible parasite to cause 
persistent neuropsychiatric diseases such as schizophrenia because of its known ability to alter 
key neurotransmitter levels such as dopamine and glutamate, as well as its ability to affect 
neurons and cognitive function. T. gondii in culture has also been shown to be inhibited by 
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some antipsychotics and mood stabilizers frequently used as treatments for mental disorders 
such as schizophrenia (Mortensen et al., 2007). 
 A second study already mentioned that more recently explored the relationship 
between T. gondii and schizophrenia was performed in Tunisia, a country located in northern 
Africa between the Sahara Desert and the Mediterranean Sea. This study was performed similar 
to Mortensen’s study by observing the IgG antibody levels against the parasite in both 
schizophrenic subjects and control subjects. Esshili found the rate of infection by T. gondii in 
schizophrenic patients was statistically higher than in control patients, also claiming that the 
parasitic infection increased the risk for schizophrenia by about 2.5 times (2016). This is not to 
say T. gondii is a direct cause or indicator for development of schizophrenia, but it may be 
involved as a cofactor along with other factors such as genetics and environment. T. gondii does 
have a direct impact on the brain and immune system mechanisms and affects 
neurotransmission, as previously discussed. T. gondii will typically infect both neurons and 
astrocytes within the brain, and these infected astrocytes and other microglia will produce pro-
inflammatory cytokines. The pro-inflammatory cytokines can then alter the glutamatergic 
neurotransmission which is a change observed in schizophrenic patients. The important part of 
the parasite’s life cycle here is the bradyzoite which, during the development, could directly 
alter dopamine biosynthesis which is observed in persons with psychotic disorders (Esshili et al., 
2016). 
Treatments and What They Target 
 In the study by Esshili et al. (2016), schizophrenic patients were treated with either a 
typical antipsychotic such as Haloperidol, Fluphenazine, or Chlorpromazine, with an atypical 
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antipsychotic such as Risperidone, Olanzapine, or Amisulpride, or with both typical and atypical 
antipsychotic medications. Over half of the patients were also taking anticholinergic 
medications (Esshili et al., 2016). There are several anti-psychotic drugs and mood stabilizers 
which have anti-T. gondii effects, although the medications were not originally prescribed to 
target the parasite. Haloperidol functions by inhibiting the effects of dopamine though 
competitively blocking post-synaptic dopamine receptors in the brain. This prevents 
neurotransmission through dopamine and can relieve delusions or hallucinations (DrugBank, 
2019d). Haloperidol is used primarily to treat schizophrenia and other forms of psychosis. 
Fluphenazine is also used in managing schizophrenia and functions through blocking 
post-synaptic mesolimbic dopamine receptors in the brain (DrugBank, 2019c). Chlorpromazine 
functions similarly to Haloperidol and Fluphenazine, and is used to treat schizophrenia, 
although unlike the other two drugs, Chlorpromazine has many other targets such as relieving 
restlessness before surgery and tetanus (DrugBank, 2019b). Risperidone and Olanzapine 
function similarly to the other drugs already described for schizophrenia. Amisulpride is slightly 
different from the other drugs in that at low doses it binds to and blocks pre-synaptic dopamine 
receptors which enhances dopaminergic transmission, while at higher doses it blocks post-
synaptic dopamine receptors to prevent hyperactivity (DrugBank, 2019a). 
 Fluphenazine, Haloperidol, and the mood stabilizer valproic acid have been 
found to be powerful and specific inhibitors of T. gondii reproduction during in vitro cultivation 
(Flegr, 2015). Nearly all modern antipsychotics either decrease the dopamine concentration or 
downregulate the activity of its receptors on neural cells (Flegr, 2015). There may be causes 
other than T. gondii infection for the increased dopamine levels seen in schizophrenic patients. 
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However, the drugs which decrease dopamine and have been found to inhibit replication of T. 
gondii provide evidence that T. gondii may likely be a contributing factor to schizophrenia. 
Conclusion 
 Toxoplasma gondii is a parasite known to be transmitted from cats to humans most 
commonly through contact with cat feces. It is suggested this parasite infects almost forty 
million Americans, although most infections in humans are latent and never cause any 
problems because a healthy person’s immune system can normally fight off the infection. 
Pregnant women and immune compromised individuals are at much greater risk for 
reactivation of the T. gondii infection. Some of the most common ways humans are infected is 
through contact with contaminated cat feces, vertical transmission from mother to child, 
horizontal transmission through infected transplant organs, and through ingesting infected 
animals due to cultural beliefs or habits. Toxoplasma gondii has been of interest to researchers 
since the 1950s because of the effect it has on rats. Some studies have shown that rats infected 
with T. gondii lose their instinctual fear of cat urine, making them more likely to become prey. 
Furthering research on T. gondii has shifted to a focus on the proposed effects of the parasite in 
humans, and the possible link to schizophrenia.  
 The parasite can infect almost any warm-blooded species and can enter the central 
nervous system using pseudo-kinase proteins which inactivate host GTPases involved in the 
host’s immune system. Once in the central nervous system, the parasite is proposed to exert an 
effect on the dopaminergic neurons to increase dopamine neurotransmission. Areas of the 
human brain that are particularly susceptible to changes in dopamine levels are the amygdala, 
nucleus accumbens, and other limbic regions of the brain. Alterations of dopamine metabolism 
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may be linked to the increased aggressivity and impulsiveness associated with T. gondii 
infection. There have also been studies on the possibility of T. gondii having a role in 
schizophrenia. Schizophrenia as a disease is not well understood as to what its exact cause is, 
but it is well known that increased dopamine levels play a significant role.  
Other proposed theories suggest that infected astrocytes and microglia in the brain 
release pro-inflammatory cytokines which alter the glutamatergic or dopaminergic 
neurotransmission, changes in which are associated with schizophrenia. There are anti-
psychotic and mood stabilizer drugs such as Haloperidol which inhibit dopamine transmission. 
Haloperidol and other anti-psychotics used in the treatment of schizophrenia not only decrease 
dopamine but have also been shown to inhibit replication of T. gondii. T. gondii has been 
associated with increased levels of dopamine in both rats and humans, so it is likely that drugs 
such as Haloperidol decrease dopamine because they inhibit T. gondii. The studies presented 
here are only a few of many that provide increasing evidence for an association between T. 
gondii and schizophrenia. Further research is necessary to increase support of these findings 
and to enhance the understanding of schizophrenia as a disease itself. 
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